Bergeron C, and Ferenczy, A. (2001) Endometrial Safety of Continuous Combined Hormone Replacement Therapy with 17β-Oestradiol (1 or 2 mg) and Dydrogesterone. Maturitas, 37, 191-199. http://dx.doi.org/10.1016/S0378-5122(00)00176-6

has been cited by the following article:

• TITLE: Efficacy of the Levonorgestrel-Releasing Intrauterine Device as an Alternative to Oral Progesterone in the Management of Endometrial Hyperplasia without Atypia

  AUTHORS: Hend S. Saleh, Moustafa A. Ibrahiem, Ebtesam M. Kamal, Mohamed El Sayed Mohamed, Manal M. El Behery

  KEYWORDS: Endometrial Hyperplasia, Progesterone, LNG-IUS, Mirena

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.4 No.7, May 13, 2014

  ABSTRACT: The following article has been retracted due to the strong authorship problem regarding publication and the first author of this manuscript is insisting to withdraw it. This paper published in Vol. 4 No. 7 349-355, 2014, has been removed from this site.